Skip to main content

Market Overview

41 Stocks Moving In Monday's Mid-Day Session

Share:

Gainers

  • Dare Bioscience Inc (NASDAQ: DARE) shares climbed 132.7% to $1.95 after the company announced an exclusive licensing agreement with Bayer for US commercial rights to Ovaprene. Dare will receive an upfront payment of $20 million and up to $310 million in milestones.
  • Mereo BioPharma Group plc (NASDAQ: MREO) gained 37.2% to $2.88 after the company announced it has entered into a global licensing agreement with Oncologie for Navicixizumab. Mereo will receive an upfront payment of $4 million with an additional $2 million payment conditional on CMC milestone and up to $300 million in future milestones.
  • CounterPath Corporation (NASDAQ: CPAH) shares rose 33% to $5.28 after climbing 304.12% on Friday.
  • Primo Water Corporation (NASDAQ: PRMW) shares jumped 25% to $13.85 after the company agreed to be acquired by Cott Corp (NYSE: COT) for $14 per share.
  • Verona Pharma plc (NASDAQ: VRNA) rose 23.8% to $7.38. Verona Pharma reported primary endpoint met at all doses in 4 week Phase 2b COPD study with nebulized ensifentrine on top of tiotropium therapy.
  • Cardlytics Inc (NASDAQ: CDLX) gained 20% to $81.78 after the company raised its Q4 sales guidance above analyst estimates.
  • Alphatec Holdings Inc (NASDAQ: ATEC) gained 14% to $7.40.
  • BroadVision, Inc. (NASDAQ: BVSN) climbed 13.4% to $2.80.
  • Ballard Power Systems Inc. (NASDAQ: BLDP) rose 13.2% to $10.30 after gaining 5.59% on Friday.
  • Enlivex Therapeutics Ltd. (NASDAQ: ENLV) rose 11.4% to $9.36.
  • Trillium Therapeutics Inc (NASDAQ: TRIL) jumped 11% to $3.05 after the company raised FY2019 sales guidance.
  • MRI Interventions Inc (NASDAQ: MRIC) gained 10.5% to $5.69. MRI Interventions obtained $17.5 million strategic investment from PTC Therapeutics, Inc. and Petrichor Healthcare Capital Management.
  • TerraForm Power Inc (NASDAQ: TERP) gained 10.3% to $17.20 after the company confirmed the receipt of unsolicited proposal from Brookfield Renewable for 0.36 Brookfield Shares for each Terraform share owned.
  • Beyond Meat, Inc. (NASDAQ: BYND) shares rose 10% to $105.58. Chinese plant-based meat substitute founder Vince Lu said entrance of Beyond Meat, Impossible Foods to China can raise the exposure of plant-based foods in the country.
  • Venator Materials PLC (NYSE: VNTR) gained 9.9% to $3.57.
  • CareDx Inc (NASDAQ: CDNA) gained 9.5% to $21.69 after the company raised FY2019 sales guidance.
  • OncoCyte Corp (NYSE: OCX) rose 7% to $2.84 after the company announced plans to acquire Insight Genetics for $12 million.
  • ObsEva SA (NASDAQ: OBSV) rose 6.8% to $3.79. ObsEva and Yuyuan BioScience Technology announced sublicense agreement to develop and commercialize Nolasiban in the People's Republic of China.
  • Invitae Corporation (NYSE: NVTA) rose 6.5% to $17.80. Invitae said it generated revenue of $216 million in 2019, up more than 45% versus the $147.7 million in 2018.
  • At Home Group Inc. (NYSE: HOME) rose 6.5% to $5.42 after the company raised Q4 and FY20 EPS guidance above analyst estimates.
  • Amarin Corporation plc (NASDAQ: AMRN) rose 6.5% to $20.18. Amarin reported the launche of True To Your Heart, a campaign to educate people on persistent cardiovascular risk.
  • Jumei International Holding Limited (NYSE: JMEI) shares rose 5.9% to $18.73 after falling 5.78% on Friday.

 

Check out these big penny stock gainers and losers

Losers

  • Acasti Pharma Inc (NASDAQ: ACST) shares dipped 73.2% to $0.58 after the company announced its TRILOGY 1 Phase 3 trial of CaPre did not reach statistical significance.
  • Stage Stores, Inc. (NYSE: SSI) fell 55.5% to $3.24 after the company reported a 1.4% year-over-year rise in its holiday same-store sales. The company announced it expects full-year 2019 earnings to be $25 million to $30 million below the low end of the previously announced guidance range.
  • Aquestive Therapeutics Inc (NASDAQ: AQST) dropped 29.2% to $4.68. Aquestive Therapeutics received FDA response denying Aquestive's Citizen's petition received by the FDA on November 1, 2019.
  • Ameri Holdings Inc (NASDAQ: AMRH) dipped 24% to $1.85 after the company announced it plans to merge with Jay Pharma.
  • Tilly's Inc (NYSE: TLYS) dropped 21% to $9.20 after the company reported a 2% drop in holiday same-store sales and issued weak Q4 earnings forecast.
  • Inogen Inc (NASDAQ: INGN) fell 20.7% to $48.53 after the company issued weak sales forecast.
  • ABIOMED, Inc. (NASDAQ: ABMD) dipped 16% to $158.71 after the company issued Q3 and FY20 sales guidance below analyst estimates.
  • Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC) fell 16% to $0.76 after the company announced it received a notice of delisting or failure to satisfy a continued listing rule or standard.
  • Five Below Inc (NASDAQ: FIVE) dropped 15% to $102.92 after the company issued preliminary Q4 & FY20 EPS and sales guidance below analyst estimates.
  • Cassava Sciences Inc (NASDAQ: SAVA) dropped 13.5% to $7.05.
  • SemiLEDs Corporation (NASDAQ: LEDS) dropped 13.5% to $2.11.
  • Salarius Pharmaceuticals Inc (NASDAQ: SLRX) dipped 12.4% to $3.31.
  • Magenta Therapeutics Inc (NASDAQ: MGTA) shares fell 12.3% to $13.37.
  • Carrols Restaurant Group Inc (NASDAQ: TAST) fell 11.6% to $6.00.
  • EXACT Sciences Corporation (NASDAQ: EXAS) dropped 11.3% to $92.62 despite the company's upbeat Q4 and FY19 sales guidance issued on Sunday.
  • AxoGen, Inc (NASDAQ: AXGN) fell 10.9% to $14.17 after the company issued FY20 sales forecast.
  • BioNTech SE – ADR (NASDAQ: BNTX) dipped 10.5% to $35.52. Iovance Biotherapeutics and Cellectis entered into a research collaboration and exclusive worldwide license agreement.
  • Iovance Biotherapeutics Inc (NASDAQ: IOVA) dropped 10.3% to $24.35.
  • Cyclerion Therapeutics, Inc. (NASDAQ: CYCN) fell 9.7% to $3.08.
 

Related Articles (ABMD + ACST)

View Comments and Join the Discussion!

Posted-In: Mid-Day MoversNews Movers & Shakers Intraday Update Markets Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com